FindTrial
Sign In

Comparison of three ganciclovir-based strategies for cytomegalovirus prophylaxis after renal transplantation

Comparison of three ganciclovir-based strategies for cytomegalovirus prophylaxis after renal transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-PNRC-12002162
Enrollment
Unknown
Registered
2012-05-09
Start date
1995-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal transplantation

Interventions

3:useing ganciclovir

Sponsors

First Affiliated Hospital, Medical college, Xi’an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: received renal transplantation, without CMV infection before transplantation,

Exclusion criteria

Exclusion criteria: combined multiple organs transplantation with CMV infection before transplantation, with other infection before transplantation,

Design outcomes

Primary

MeasureTime frame
infection rate;—

Secondary

MeasureTime frame
rejection rate;cost;—

Countries

China

Contacts

Public ContactWujun Xue
leon4344@126.com+86 029 85323955

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026